FabiFlu: Anti-Covid drug now top-selling pharma brand
Anti-viral drug FabiFlu, which is used in treating COVID-19, has registered a 600 percent jump in sales for the month of April and is now the largest selling pharma brand in India for the first time.
May 11, 2021, 16:21 PM ISTGlenmark defends price of its COVID-19 drug favipiravir version
Glenmark also denied making any claims that "favipiravir alone" is effective in treatment of mild-to-moderate COVID-19 patients.
Jul 21, 2020, 12:20 PM ISTGlenmark, Cipla stocks surge after nod to launch drugs for COVID-19
The Nifty pharma index was trading higher by 2.62 percent at 10264.45 at 2.41 pm.
Jun 22, 2020, 14:46 PM ISTFDCs banned over safety & efficacy concerns: Centre tells HC
The hearing in the matter would continue on April 4.
Apr 01, 2016, 00:41 AM ISTP&G to resume manufacturing, sale of Vicks Action 500 Extra
FMCG firm Procter and Gamble (P&G) today said it will resume manufacturing and sale of its popular brand 'Vicks Action 500 Extra' after the Delhi High Court stayed government's order banning fixed dose combination drugs
Mar 16, 2016, 22:29 PM ISTHC restrains Glenmark from business of anti-diabetes drugs
In a relief for US drug major Merck Sharp and Dohme (MSD), Delhi High Court on Wednesday restrained Indian firm Glenmark Pharmaceuticals from manufacturing and selling its anti-diabetes drugs Zita and Zita-Met, saying it has infringed patent of the American company.
Oct 07, 2015, 12:16 PM ISTGlenmark receives USFDA nod for oral contraceptive drug
"Glenmark Pharmaceuticals Inc., USA has been granted final approval by the United States Food & Drug Administration (USFDA) for Drospirenone and Ethinyl Estradiol tablets USP, 3 mg/0.02 mg," the company said in a BSE filing.
Aug 19, 2015, 11:47 AM ISTUS court rejects Glenmark's patent plea for Finacea
Drug firm Glenmark's generic skin care drug that was under patent litigation infinges patent of Bayer, a US court has ruled.
Jul 28, 2015, 23:25 PM ISTGlenmark gets USFDA nod for generic diabetes treatment drug
Shares of Glenmark Pharmaceuticals were trading at Rs 874.75 per scrip in afternoon trade, up 2.04 percent from the previous close on the BSE.
May 29, 2015, 12:49 PM ISTGlenmark gets tentative USFDA nod to sell Rufinamide
Rufinamide is used to treat seizures caused by Lennox-Gastaut syndrome.
May 21, 2015, 12:54 PM ISTGlenmark to pay $24.96 mn to US to settle pricing probe
In a regulatory filing with the National Stock Exchange, the company said that under the terms of the agreed settlement, "there is no admission of liability".
Apr 08, 2015, 17:50 PM ISTGlenmark's subsidiary to pay $25 mn to settle a pricing case
Pharmaceutical major Glenmark on Wednesday said its US subsidiary will pay USD 25 million to the federal government there as well as to the Texas state administration to settle a pricing investigation.
Apr 08, 2015, 13:14 PM ISTGlenmark gets USFDA nod for post-menopause osteoporosis drug
The approval for sale of Norethindrone Acetate and Ethinyl Estradiol tablets was given to Glenmark Generics Inc USA, a subsidiary of Glenmark Generics Ltd.
Apr 07, 2015, 12:11 PM ISTSC stays Delhi HC order till April 28 against Glenmark
Supreme Court today stayedtill April 28 the order of Delhi High Court barring Indian pharma major Glenmark Pharamceuticals from making, marketing or selling its anti-diabetes medicines in which US drug major Merck Sharp and Dohme (MSD) has claimed patent right.
Mar 25, 2015, 19:55 PM ISTFIPB refers Rs 4,197 cr Glenmark, Aurobindo proposals to CCEA
The Finance Ministry Thursday referred the foreign investment proposals worth Rs 4,187 crore in pharma firms - Glenmark and Aurobindo - to the Cabinet Committee on Economic Affairs.
Feb 19, 2015, 21:15 PM ISTFDI proposals worth Rs 1,075.91 cr cleared; Glenmark, Aurobindo sent to CCEA
FIPB has cleared foreign investment in 11 entities, entailing Rs 1,075.91 crore, and referred proposals worth Rs 4,187 crore in pharma firms - Glenmark and Aurobindo - to the Cabinet Committee on Economic Affairs.
Feb 19, 2015, 21:13 PM ISTGlenmark bullish on drug discovery pipeline, eyes partnerships
As many as six out of seven molecules in Glenmark's drug discovery pipeline are currently in the clinical trial stage and the company's R&D spend pegged at 10 percent of sales is expected to be maintained at similar levels for next two years, a top official has said.
Feb 15, 2015, 20:55 PM ISTGlenmark bullish on drug discovery pipeline, eyes partnerships
Pain, inflammation and oncology are the therapeutic areas currently the drug maker is working on, said Glenn Saldanha, Chairman & Managing Director, Glenmark Pharmaceuticals Ltd.
Feb 15, 2015, 11:00 AM ISTGlenmark Q3 net dips 47 pc at Rs 114.77 cr
Glenmark Pharmaceuticals today reported a 46.92 per cent dip in its consolidated net profit at Rs 114.77 crore for the quarter ended December 31, 2014 mainly due to forex losses and increased expenses.
Feb 12, 2015, 19:23 PM ISTHC sets aside restraint on Glenmark from making an antibiotic
Delhi High Court today set aside its single judge's order restraining Mumbai-based generic drug maker Glenmark Pharmaceuticals Ltd from making and selling its antibiotic medicine Linezolid.
Feb 05, 2015, 15:32 PM IST